Navigation Links
SpectraScience Strengthens Leadership Team With Four Key Hires
Date:2/19/2008

SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has hired several individuals to drive its operational growth as it moves from an R&D focus towards a revenue generating business model in 2008:

-- Todd Pinkowski - Director of Operations of WavSTAT(TM)

-- Michael Brady - Director of Engineering

-- Charles Negus - Director of Operations of LUMA(TM)

-- Glen Freiburg - Vice President of Regulatory Affairs to oversee the

Company's regulatory progress in bringing new products to market

Jim Hitchin, SpectraScience's CEO, stated, "The addition of these senior members to our team is critical in our go-to-market strategy for 2008. We expect to ramp-up operations this year and have recently expanded our facilities to accommodate increased production. With these new team members, we expect to strengthen our business model and drive sales. These new leaders are part of our continuing evolution to become a major player in the burgeoning market for early disease detection and point of care diagnostics."

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-KSB and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-KSB and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT(TM) Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA clearance for sale in the U.S. and the CE Mark for the European Union, the WavSTAT(TM) system is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA(TM) imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.

Contact:

SpectraScience, Inc.

Jim Hitchin, Chief Executive Officer

(858) 847-0200 x201 http://www.spectrascience.com

Hayden Communications

Investor Relations - Todd Pitcher (858) 518-1387


'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Jim Dorst Joins SpectraScience as CFO
2. SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
3. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
4. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
5. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
6. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
7. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
8. Anavex strengthens Board of Directors
9. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
10. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
11. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight ... for Cancer Research (OICR) are pleased to report that ... A financing, with Johnson & Johnson Innovation – JJDC, ... include venture groups HealthCap, TPG Biotechnology Partners, and Genesys ... ...
(Date:2/23/2017)... -- Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, parks and ... lice treatment salon to set up shop. But there,s ... French bistro on E Madison Ave, and CEO Maria ... lice clinic, we pride ourselves on being a destination for ... the stigma associated with lice. Everyone can get lice – ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in a published evaluation of multiple immunoassay-based threat detection technologies by researchers ... Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have the ...
(Date:2/23/2017)... NC (PRWEB) , ... February 23, 2017 , ... ... to announce a new partnership with Compass Research . GGI's mission is to ... a vaccine to a child in need in honor of each clinical trial volunteer. ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/26/2017)... -- Crossmatch, a leading provider of security and identity management ... fraud, waste and abuse in assistance operations around the ... Disaster Relief conference in Panama City ... foreign assistance organizations throughout Latin America ... largely unacknowledged problem in the foreign assistance and disaster ...
(Date:1/24/2017)... Jan. 24, 2017  It sounds simple and ... that monitors vital signs and alerts parents on ... oxygen saturation level drops. But pediatric experts argue ... parents, with no evidence of medical benefits, especially ... marketed aggressively to parents of healthy babies, promising ...
Breaking Biology News(10 mins):